S21-1011
S21-1011 is a selective inhibitor for butyrylcholinesterase (BChE), with IC50 of 0.059 and 0.162 μM, for eqBChE and hBChE, respectively. S21-1011 exhibits good blood-brain barrier (BBB) permeability and good pharmacokinetic characters. S21-1011 exhibits anti-inflammatory activity through activation of keap1-Nrf2-ARE pathway (EC50 is 23.48 μM for antioxidant element ARE activation), ameliorates cognitive impairment in murine Alzheimer’s disease model[1].
Product Specifications
CAS Number
2671859-87-1
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Keap1-Nrf2
Type
Reference compound
Related Pathways
Neuronal Signaling; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/s21-1011.html
Smiles
CCCC1=CC=C(C(NC2=CN=C(C=CC=C3)C3=C2N4CCN(CC5=CC=CC=C5)CC4)=O)C=C1
Molecular Formula
C30H32N4O
Molecular Weight
464.60
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Multiplex Assay Kit for Peroxisome Proliferator Activated Receptor Delta (PPARd), etc. by FLIA (Flow Luminescence Immunoassay)
UPK1B (uroplakin 1B, TSPAN20, UPIB, UPK1) (MaxLight 650)
Aedes aegypti (Yellowfever mosquito) AeAgo2 Antibody
RFFL, CT (RFFL, RNF189, RNF34L, E3 ubiquitin-protein ligase rififylin, Caspase regulator CARP2, Caspases-8 and-10-associated RING finger protein 2, FYVE-RING finger protein Sakura, RING finger and FYVE-like domain-containing protein 1, RING finger protein